105 related articles for article (PubMed ID: 26402875)
1. Germline Mutations of BRCA1 and BRCA2 in Korean Ovarian Cancer Patients: Finding Founder Mutations.
Choi MC; Heo JH; Jang JH; Jung SG; Park H; Joo WD; Lee C; Lee JH; Lee JM; Hwang YY; Kim SJ
Int J Gynecol Cancer; 2015 Oct; 25(8):1386-91. PubMed ID: 26402875
[TBL] [Abstract][Full Text] [Related]
2. Contribution of BRCA1 and BRCA2 germline mutations to early onset breast cancer: a series from north of Morocco.
Bakkach J; Mansouri M; Derkaoui T; Loudiyi A; El Fahime E; Barakat A; Ghailani Nourouti N; Martinez De Villarreal J; Cortijo Bringas C; Bennani Mechita M
BMC Cancer; 2020 Sep; 20(1):859. PubMed ID: 32894085
[TBL] [Abstract][Full Text] [Related]
3. Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-gene Panels: Beyond BRCA1/2.
Eoh KJ; Kim JE; Park HS; Lee ST; Park JS; Han JW; Lee JY; Kim S; Kim SW; Kim JH; Kim YT; Nam EJ
Cancer Res Treat; 2018 Jul; 50(3):917-925. PubMed ID: 29020732
[TBL] [Abstract][Full Text] [Related]
4. Germline mutations in BRCA1 and BRCA2 among Brazilian women with ovarian cancer treated in the Public Health System.
de Oliveira Ferreira C; Carneiro VCG; Araujo Mariz C
BMC Cancer; 2024 Apr; 24(1):499. PubMed ID: 38641594
[TBL] [Abstract][Full Text] [Related]
5. Management challenges in low-grade serous ovarian cancer with a BRCA mutation.
Sanchez-Lorenzo L; Sancho L; Iscar T; Grisham R; Chiva L
Int J Gynecol Cancer; 2024 Apr; 34(4):631-636. PubMed ID: 38561200
[No Abstract] [Full Text] [Related]
6. Characteristics of germline DNA damage response gene mutations in ovarian cancer in Southwest China.
Fu K; Li Q; Wang J; Zhang M; Yan X; Li K; Song L; Zhong L; Ma Y; Chen J; Zeng J; Wang D; Shao D; Zhu S; Yin R
Sci Rep; 2024 Mar; 14(1):6702. PubMed ID: 38509102
[TBL] [Abstract][Full Text] [Related]
7. Deleterious and ethnic-related BRCA1/2 mutations in tissue and blood of Egyptian colorectal cancer patients and its correlation with human papillomavirus.
Youssef ASE; Zekri ARN; Mohanad M; Loutfy SA; Abdel Fattah NF; Elberry MH; El Leithy AA; El-Touny A; Rabie AS; Shalaby M; Hanafy A; Lotfy MM; El-Sisi ER; El-Sayyad GS; Nassar A
Clin Exp Med; 2023 Dec; 23(8):5063-5088. PubMed ID: 37804357
[TBL] [Abstract][Full Text] [Related]
8. Patterns and predictors of genetic referral among ovarian cancer patients at a National Cancer Institute-Comprehensive Cancer Center.
Mallen AR; Conley CC; Townsend MK; Wells A; Boac BM; Todd S; Gandhi A; Kuznicki M; Augusto BM; McIntyre M; Fridley BL; Tworoger SS; Wenham RM; Vadaparampil ST
Clin Genet; 2020 Feb; 97(2):370-375. PubMed ID: 31600840
[TBL] [Abstract][Full Text] [Related]
9. Association between prostate cancer characteristics and BRCA1/2-associated family cancer history in a Japanese cohort.
Ishiyama Y; Shimbo M; Iizuka J; Deshpande G; Tanabe K; Hattori K
PLoS One; 2020; 15(12):e0244149. PubMed ID: 33351846
[TBL] [Abstract][Full Text] [Related]
10. Identification of
Li J; Han S; Zhang C; Luo Y; Wang L; Wang P; Wang Y; Xia Q; Wang X; Wei B; Ma J; Li H; Guo Y
Front Oncol; 2021; 11():655709. PubMed ID: 34046351
[TBL] [Abstract][Full Text] [Related]
11. Better therapeutic trials in ovarian cancer.
Bookman MA; Gilks CB; Kohn EC; Kaplan KO; Huntsman D; Aghajanian C; Birrer MJ; Ledermann JA; Oza AM; Swenerton KD
J Natl Cancer Inst; 2014 Apr; 106(4):dju029. PubMed ID: 24627272
[TBL] [Abstract][Full Text] [Related]
12. BRCA1/2 and Endometrial Cancer Risk: Implications for Management.
Sherman ME; Foulkes WD
J Natl Cancer Inst; 2021 Sep; 113(9):1127-1128. PubMed ID: 33710310
[No Abstract] [Full Text] [Related]
13. Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients.
Zhong X; Dong Z; Dong H; Li J; Peng Z; Deng L; Zhu X; Sun Y; Lu X; Shen F; Su X; Zhang L; Gu Y; Zheng H
PLoS One; 2016; 11(6):e0156789. PubMed ID: 27257965
[TBL] [Abstract][Full Text] [Related]
14. RAD51C mutation screening in high-risk patients from Serbian hereditary breast/ovarian cancer families.
Krivokuca A; Yanowski K; Rakobradovic J; Benitez J; Brankovic-Magic M
Cancer Biomark; 2015; 15(6):775-81. PubMed ID: 26406419
[TBL] [Abstract][Full Text] [Related]
15. Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.
Nykamp K; Anderson M; Powers M; Garcia J; Herrera B; Ho YY; Kobayashi Y; Patil N; Thusberg J; Westbrook M; ; Topper S
Genet Med; 2017 Oct; 19(10):1105-1117. PubMed ID: 28492532
[TBL] [Abstract][Full Text] [Related]
16. Unclassified Variants of BRCA1 and BRCA2 in Korean Patients With Ovarian Cancer.
Choi MC; Jang JH; Jung SG; Park H; Joo WD; Song SH; Lee C; Lee JH
Int J Gynecol Cancer; 2018 Feb; 28(2):308-315. PubMed ID: 29240602
[TBL] [Abstract][Full Text] [Related]
17. Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers?
Semple J; Metcalfe KA; Lubinski J; Huzarski T; Gronwald J; Armel S; Lynch HT; Karlan B; Foulkes W; Singer CF; Neuhausen SL; Eng C; Iqbal J; Narod SA;
Breast Cancer Res Treat; 2015 Nov; 154(1):163-9. PubMed ID: 26467043
[TBL] [Abstract][Full Text] [Related]
18. Multigene panel analysis identified germline mutations of DNA repair genes in breast and ovarian cancer.
Hirotsu Y; Nakagomi H; Sakamoto I; Amemiya K; Oyama T; Mochizuki H; Omata M
Mol Genet Genomic Med; 2015 Sep; 3(5):459-66. PubMed ID: 26436112
[TBL] [Abstract][Full Text] [Related]
19. Functional assays provide a robust tool for the clinical annotation of genetic variants of uncertain significance.
Woods NT; Baskin R; Golubeva V; Jhuraney A; De-Gregoriis G; Vaclova T; Goldgar DE; Couch FJ; Carvalho MA; Iversen ES; Monteiro AN
NPJ Genom Med; 2016; 1():16001-. PubMed ID: 28781887
[TBL] [Abstract][Full Text] [Related]
20. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation.
Gayther SA; Warren W; Mazoyer S; Russell PA; Harrington PA; Chiano M; Seal S; Hamoudi R; van Rensburg EJ; Dunning AM; Love R; Evans G; Easton D; Clayton D; Stratton MR; Ponder BA
Nat Genet; 1995 Dec; 11(4):428-33. PubMed ID: 7493024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]